Executive Summary
OrganoClick AB (publ), a material and chemical technology company, develops, produces, and markets fiber-based materials and chemicals in Sweden. More Details
Rewards
Risk Analysis
No risks detected for ORGC from our risk checks.
Snowflake Analysis
Exceptional growth potential with adequate balance sheet.
Share Price & News
How has OrganoClick's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ORGC is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: ORGC's weekly volatility (7%) has been stable over the past year.
Market Performance
7 Day Return
6.2%
ORGC
3.2%
SE Chemicals
1.6%
SE Market
1 Year Return
84.4%
ORGC
4.7%
SE Chemicals
15.6%
SE Market
Return vs Industry: ORGC exceeded the Swedish Chemicals industry which returned 8.1% over the past year.
Return vs Market: ORGC exceeded the Swedish Market which returned 17.1% over the past year.
Shareholder returns
| ORGC | Industry | Market | |
|---|---|---|---|
| 7 Day | 6.2% | 3.2% | 1.6% |
| 30 Day | -7.3% | 7.4% | 5.6% |
| 90 Day | 50.9% | 8.8% | 10.9% |
| 1 Year | 84.4%84.4% | 7.0%4.7% | 18.7%15.6% |
| 3 Year | 65.4%65.4% | 20.0%11.8% | 48.6%30.9% |
| 5 Year | 56.9%56.9% | 16.7%0.9% | 87.5%47.6% |
Long-Term Price Volatility Vs. Market
How volatile is OrganoClick's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall St
What Percentage Of OrganoClick AB (publ) (STO:ORGC) Shares Do Insiders Own?1 month ago | Simply Wall St
Analysts Expect Breakeven For OrganoClick AB (publ) (STO:ORGC) Before Long1 month ago | Simply Wall St
Calculating The Fair Value Of OrganoClick AB (publ) (STO:ORGC)Valuation
Is OrganoClick undervalued compared to its fair value and its price relative to the market?
8.8%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ORGC (SEK9.96) is trading below our estimate of fair value (SEK10.92)
Significantly Below Fair Value: ORGC is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: ORGC is unprofitable, so we can't compare its PE Ratio to the SE Chemicals industry average.
PE vs Market: ORGC is unprofitable, so we can't compare its PE Ratio to the Swedish market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ORGC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ORGC is overvalued based on its PB Ratio (14.4x) compared to the SE Chemicals industry average (7.9x).
Next Steps
Future Growth
How is OrganoClick forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
113.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ORGC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.4%).
Earnings vs Market: ORGC is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ORGC's is expected to become profitable in the next 3 years.
Revenue vs Market: ORGC's revenue (40% per year) is forecast to grow faster than the Swedish market (3.4% per year).
High Growth Revenue: ORGC's revenue (40% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ORGC's Return on Equity is forecast to be high in 3 years time (34.1%)
Next Steps
Past Performance
How has OrganoClick performed over the past 5 years?
2.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ORGC is currently unprofitable.
Growing Profit Margin: ORGC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ORGC is unprofitable, but has reduced losses over the past 5 years at a rate of 2.8% per year.
Accelerating Growth: Unable to compare ORGC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ORGC is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-12%).
Return on Equity
High ROE: ORGC has a negative Return on Equity (-20.53%), as it is currently unprofitable.
Next Steps
Financial Health
How is OrganoClick's financial position?
Financial Position Analysis
Short Term Liabilities: ORGC's short term assets (SEK69.3M) exceed its short term liabilities (SEK43.5M).
Long Term Liabilities: ORGC's short term assets (SEK69.3M) exceed its long term liabilities (SEK24.6M).
Debt to Equity History and Analysis
Debt Level: ORGC's debt to equity ratio (17.9%) is considered satisfactory.
Reducing Debt: ORGC's debt to equity ratio has increased from 12.8% to 17.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ORGC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ORGC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Next Steps
Dividend
What is OrganoClick current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ORGC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ORGC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ORGC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ORGC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ORGC's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
8.0yrs
Average management tenure
CEO
Marten Hellberg (40 yo)
15yrs
Tenure
kr1,394,000
Compensation
Mr. Marten Hellberg serves as Director at Svenska Aerogel Holding AB (publ) since June 11, 2018. He Co-founded OrganoClick AB in 2006 and has been its Chief Executive Officer since 2006 and has been its Pr...
CEO Compensation Analysis
Compensation vs Market: Marten's total compensation ($USD168.15K) is below average for companies of similar size in the Swedish market ($USD241.80K).
Compensation vs Earnings: Marten's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 15yrs | kr1.39m | 8.01% SEK 73.8m | |
| Chief Financial Officer | 8yrs | no data | 0.16% SEK 1.5m | |
| Chief Operating Officer | 2.67yrs | no data | 0.0011% SEK 10.0k | |
| Research & Development Director | no data | no data | 0.016% SEK 147.4k |
8.0yrs
Average Tenure
Experienced Management: ORGC's management team is seasoned and experienced (8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 5yrs | kr400.00k | 0.18% SEK 1.7m | |
| Director | 4.33yrs | kr100.00k | no data | |
| Director | 0.67yr | no data | no data | |
| Director | 13yrs | kr100.00k | 0.75% SEK 6.9m | |
| Director | 0.67yr | no data | no data |
4.3yrs
Average Tenure
62yo
Average Age
Experienced Board: ORGC's board of directors are considered experienced (4.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ORGC insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
OrganoClick AB (publ)'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: OrganoClick AB (publ)
- Ticker: ORGC
- Exchange: OM
- Founded: 2006
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: kr921.128m
- Shares outstanding: 92.11m
- Website: https://www.organoclick.com
Number of Employees
Location
- OrganoClick AB (publ)
- Linjalvägen 9
- Täby
- Stockholm County
- 187 66
- Sweden
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ORGC | OM (OMX Nordic Exchange Stockholm) | Yes | Common Shares | SE | SEK | Feb 2015 |
| 0CF | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Feb 2015 |
Biography
OrganoClick AB (publ), a material and chemical technology company, develops, produces, and markets fiber-based materials and chemicals in Sweden. It offers OrganoWood, a wooden material that is resistant t...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/22 20:30 |
| End of Day Share Price | 2021/01/22 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.